Combined cellular and immunosuppressive therapies
US5670148A · kind A · utility
30Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 1994 |
| Grant date | Sep 23, 1997 |
| Priority date | — |
| Expiry date | Sep 28, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel regimens are provided for administering foreign genetically modified allogeneic cells to a host by combining the administration of the cells with a reduced regimen of an immunosuppressive agent. Particularly, cells having a reduced level of Class I MHC antigens may be employed in a variety of cellular therapy situations, where foreign cells are engrafted to treat diseased states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.